Table 4 |
||||
| DDC mRNA expressionaanalysis in subgroups of LSCC patients, classified according to classical clinicopathological parameters | ||||
| Variable | No. of patients | Mean ± SEb | Median | p value |
| Tumor size | ||||
| ≤ 2 cm | 8 | 40.95 ± 25.88 | 0.41 | 0.033c |
| > 2 cm | 11 | 0.42 ± 0.37 | 0.05 | |
| TNM stage | ||||
| I | 5 | 63.94 ± 39.01 | 0.52 | 0.027d |
| II | 3 | 2.65 ± 2.61 | 0.05 | |
| III | 11 | 0.42 ± 0.37 | 0.05 | |
| Histological grade | ||||
| I | 7 | 0.12 ± 0.07 | 0.05 | 0.46d |
| II | 6 | 28.22 ± 27.35 | 0.05 | |
| III | 6 | 27.03 ± 25.40 | 0.17 | |
a a.u.: arbitrary units.
b Standard error of the mean.
c Calculated using the Mann-Whitney U test.
d Calculated using the Kruskal-Wallis test.
Geomela et al. BMC Cancer 2012 12:484 doi:10.1186/1471-2407-12-484
